Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors

• Miguel Aste-Amézaga ,

  * E-mail: jose_asteamezaga@merck.com

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Ningyan Zhang,

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Janet E. Lineberger,

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Beth A. Arnold,

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Timothy J. Toner,

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Mingcheng Gu,

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Lingyi Huang,

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Salvatore Vitelli,

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Kim T. Vo,

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Peter Haytko,

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Jing Zhang Zhao,

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Frederic Baleydier,

  Affiliation Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Sarah L'Heureux,

  Affiliation Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Hongfang Wang,

  Affiliation Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Wendy R. Gordon,

  Affiliation Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Elizabeth Thoryk,

  Affiliation Department of Vaccines, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Marie Blanke Andrawes,

  Affiliation Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Kittichoat Tiyanont,

  Affiliation Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Kimberly Stegmaier,

  Affiliations Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America, Cancer Program, Broad Institute, Cambridge, Massachusetts, United States of America

  ⨯
• Giovanni Roti,

  Affiliation Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Kenneth N. Ross,

  Affiliation Cancer Program, Broad Institute, Cambridge, Massachusetts, United States of America

  ⨯
• Laura L. Franlin,

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Hui Wang,

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Fubao Wang,

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Michael Chastain,

  Affiliation Department of Molecular Profiling and Pharmacology, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Andrew J. Bett,

  Affiliation Department of Vaccines, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Laurent P. Audoly,

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• Jon C. Aster,

  Affiliation Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Stephen C. Blacklow,

  Affiliation Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
•  [ ... ],
• Hans E. Huber

  Affiliation Department of Biologics Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America

  ⨯
• [ view all ]
• [ view less ]